Cargando…
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
Macrophage migration inhibitory factor (MIF) is an upstream regulator of innate immunity, but its expression is increased in some cancers via stabilization with HSP90-associated chaperones. Here, we show that MIF stabilization is tumor-specific in an acute colitis-associated colorectal cancer (CRC)...
Autores principales: | Klemke, Luisa, De Oliveira, Tiago, Witt, Daria, Winkler, Nadine, Bohnenberger, Hanibal, Bucala, Richard, Conradi, Lena-Christin, Schulz-Heddergott, Ramona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862487/ https://www.ncbi.nlm.nih.gov/pubmed/33542244 http://dx.doi.org/10.1038/s41419-021-03426-z |
Ejemplares similares
-
HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates
por: Schulz, Ramona, et al.
Publicado: (2012) -
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan
por: Blume, Joshua, et al.
Publicado: (2023) -
The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells
por: Klemke, Luisa, et al.
Publicado: (2021) -
Role of Host and Parasite MIF Cytokines during Leishmania Infection
por: Holowka, Thomas, et al.
Publicado: (2020) -
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
por: Isermann, Tamara, et al.
Publicado: (2021)